Optiver Holding
GNOM icon

Optiver Holding’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Optiver Holding’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-138
Closed -$8K – 420
2022
Q1 		$8K Sell
138
-6,166
-98% -$389K ﹤0.01% 438
2021
Q4 		$526K Buy
6,304
+3,621
+135% +$304K ﹤0.01% 252
2021
Q3 		$239K Buy
2,683
+1,802
+205% +$169K ﹤0.01% 236
2021
Q2 		$88K Buy
+881
New +$78.1K ﹤0.01% 248

Other funds holding GNOM

Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Optiver Holding's GNOM Position: Q2 2022 in Review

Optiver Holding sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2022, closing a stake of 138 shares — an estimated $8K sold.

Optiver Holding first reported a position in GNOM in Q2 2021 and held it in 4 quarters. The position peaked at $526K in Q4 2021. 58 funds tracked by Wall St. Rank hold GNOM as of Q2 2022.

  • Optiver Holding reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
  • Optiver Holding sold 138 Global X Genomics & Biotechnology ETF shares in Q2 2022, an estimated $8K.
  • Optiver Holding first reported a position in Global X Genomics & Biotechnology ETF in Q2 2021 and held it in 4 quarters.
  • Optiver Holding's Global X Genomics & Biotechnology ETF position peaked at $526K in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2022.

Based on Optiver Holding's 13F filing for Q2 2022, filed 10 Aug 2022.